DM-Pharma
The computed 12-month bankruptcy probability of DM-Pharma is 1.9% (moderate). The 2024 annual accounts show equity of €77k and a net result of €28k. Equity is growing by ~29.1% per year across the filed fiscal years. Its solvency ranks better than 61% of 6722 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €77k |
| Net result | €28k |
| Better than sector | 61% |
| Active | 5 yrs |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 31.8% | 20.4% | |
| Net result | €28k | €4k | |
| Equity | €77k | €16k | |
| Gross operating margin | €53k | €24k | |
| Staff costs | €0 | €33k |
Show 10 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €51k |
| Net profit | €28k |
| Cash flow | €35k |
| Staff costs | €0 |
| Income taxes | €8k |
| Dividends | - |
| Total assets | €241k |
| Equity | €77k |
| Debt | €164k |
| of which ≤ 1y | €45k |
| of which > 1y | €118k |
| Working capital | €16k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 1.36 |
| Quick ratio | 1.36 |
| Working capital ratio | 6.7% |
| Solvency | 31.8% |
| Debt / equity | 2.15 |
| Long-term debt ratio | 1.55 |
| Interest coverage | 6.34 |
| Gross margin | - |
| Net margin | - |
| ROA | 11.5% |
| ROE | 36.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (22 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €241k |
| Fixed assets | 21/28 | €180k |
| Tangible fixed assets | 22/27 | €180k |
| Current assets | 29/58 | €61k |
| Amounts receivable within one year | 40/41 | €58k |
| Cash & bank | 54/58 | €2k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €241k |
| Equity | 10/15 | €77k |
| Contributions / capital | 10/11 | €3k |
| Reserves | 13 | €47k |
| Accumulated profits (losses) | 14 | €27k |
| Amounts payable | 17/49 | €164k |
| Amounts payable after one year | 17 | €118k |
| Amounts payable within one year | 42/48 | €45k |
| Trade debts payable within one year | 44 | €3k |
| Income statement | ||
| Gross operating margin | 9900 | €53k |
| Operating result | 9901 | €44k |
| Financial charges | 65 | €8k |
| Result before taxes | 9903 | €36k |
| Income taxes | 67/77 | €8k |
| Net result for the period | 9904 | €28k |
| Result to be appropriated | 9905 | €28k |
| NACE primary | Detailhandel in farmaceutische producten(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 06-01-2021 |
| Status | Active |
| Postal code | 9400 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 41003B1187/00F000 | Flanders | 1,780 m² | 1 · 200 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Of the 2 Belgian State Gazette acts we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
24-03-2026 Board meeting · Seat change
- Publication: 24/03/2026 · DM-Pharma
- Filing: 16/03/2026 · DM-Pharma
- Board meeting: 09/12/2025 · DM-Pharma
- Seat change: to: Terrasstraat 39, 9400 Appelterre, from: Gezellestraat 58, 9400 Ninove, effective_date: 2025-12-09 · DM-Pharma
Technical details
{
"facts": [
{
"date": "2026-03-24",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 24/03/2026",
"value": "24/03/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-03-16",
"type": "filing",
"quote": "NEER TER GRIFFIE VAN DE ... 16 MAART 2026",
"value": "16/03/2026",
"object": null,
"subject": "e1"
},
{
"date": "2025-12-09",
"type": "board_meeting",
"quote": "Op 09/12/2025 heeft het bevoegde bestuursorgaan als volgt beslist",
"value": "09/12/2025",
"object": null,
"subject": "e1"
},
{
"date": "2025-12-09",
"type": "seat_change",
"quote": "Het bestuur beslist dat de zetel van de vennootschap zal worden verplaatst van Gezellestraat 58, 9400 Ninove naar Terrasstraat 39, 9400 Appelterre, en dit vanaf 09/12/2025.",
"value": {
"to": "Terrasstraat 39, 9400 Appelterre",
"from": "Gezellestraat 58, 9400 Ninove",
"effective_date": "2025-12-09"
},
"object": null,
"subject": "e1",
"_value_raw": {
"to": "Terrasstraat 39, 9400 Appelterre",
"from": "Gezellestraat 58, 9400 Ninove",
"effective_date": "09/12/2025"
}
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1150,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0760.881.856",
"kind": "company",
"name": "DM-Pharma",
"attrs": {
"legal_form": "Besloten vennootschap (BV)",
"short_name": "DM-Pharma"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Laurens De Marre",
"attrs": {}
}
]
}08-01-2021 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "9400 Appelterre-Eichem, Gezellestraat 58",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1990-05-04",
"name": "DE MARRE Laurens",
"niss": null,
"address": "9400 Ninove (Appelterre-Eichem), Gezellestraat 58"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 3000,
"holder_person_name": "DE MARRE Laurens",
"is_subscriber_only": false,
"n_shares_subscribed": 1000,
"amount_subscribed_eur": 3000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 3000,
"subject_company": {
"kbo": "0760.881.856",
"name_full": "DM-Pharma",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2021-01-05",
"post_incorporation_mandates": []
}| Legal nameNL | DM-Pharma |